DONATE NOW
Sign Up for Emails
Discover what steps and tests are used in diagnosing lung cancer, including medical history, imaging tests, laboratory tests, biopsies, and biomarker tests.
Explore additional resources to help you in your role as a caregiver.
Patient Preferences and Needs projects focus on the unmet needs of survivors and care partners throughout the lung cancer journey.
We thank the following sponsors and supporters for helping to make the Early Lung Cancer Center possible.
Many types of doctors and other healthcare professionals may be a part of your comprehensive care team. Find out more about the roles and responsibilities of your medical team.
Browse additional resources selected to help you find more information and support.
Shared Decision Making projects focus on understanding what the major information needs of lung cancer patients and care partners are.
Join thousands of advocates dedicated to improving the lives of people with lung cancer.
Find out more about treatment options for lung cancer by type and stage of the cancer.
Sharing your symptoms and complete medical history can help your doctor decide on next steps.
Barriers to Optimal Care studies focus on understanding patient- and physician-specific barriers to accessing optimal care.
Participate in research by joining a patient-focused research study or accessing new treatments through clinical trials.
Take an in-depth look at many risk factors associated with lung cancer including tobacco exposure, radon, air pollution, and more.
Imaging tests for lung cancer can include a chest X-ray, CT scan, MRI, PET scan, or bone scan.
Eating a healthy diet can play an important role in lung cancer care. Ina®, a personal intelligent nutrition assistant, is available 24/7 for on-demand support.
From lung cancer research breakthroughs to interviews with leading scientists, stay up-to-date on research and the exciting progress we're making.
Explore a robust glossary of terms and acronyms related to lung cancer.
Your doctor may order a complete blood count and/or a sputum cytology to get a better understanding of your health.
We fund translational research in early detection and targeted treatment of lung cancer to improve patients' overall survival and quality of life.
Biomarker testing is essential for clinical care in NSCLC and must be part of standardized workflows.
Get information about support with practical aspects of having cancer such as transportation to and from medical appointments, basic living needs and expenses, and employment and legal issues.
Learn the facts about lung cancer and download infographics to share this information with others.
A lung cancer diagnosis can often bring financial barriers with it. Financial Treatment Program helps you manage your finances to give you peace of mind.
LUNGevity has taken the lead in responding to disruptive federal policy changes.
Communities can help offer much-needed emotional support for people with lung cancer. Discover how LUNGevity can connect you with others.
Help promote LUNGevity and lung cancer awareness as a Social Media Ambassador. Find out more about program qualifications and apply today.
Take a short quiz to see if you qualify for lung cancer screening.
LUNGevity is the largest nonprofit funder of lung cancer research thanks to our generous sponsors, partners, and donors.
Some patients find complementary therapies beneficial in addition to their lung cancer treatments. Find out more about common complementary practices.
View and download materials about lung cancer, raising awareness in your community, and vital support services for survivors and their loved ones.
The results are in, and now what? Learn about the important steps you need to take after a follow-up screening.
Learn more about the specific research awards we're offering this year.
Finding lung cancer early on can make a difference. Learn about early detection and all the details you need to know about the screening process.
Honor or remember a loved one by creating a LUNGevity Tribute Fund, a fundraising campaign established in honor of them that you and others can donate to.
Learn about events in your area and how you can start your own DIY fundraiser
Learn about LUNGevity’s survivorship conferences, which are designed to inform, connect, and empower anyone who has been affected by lung cancer.
Learn about what lung cancer staging is, when and how it is determined, and what each specific stage means for you.
Not all lung cancers are the same. Comprehensive biomarker testing can identify specific genetic “drivers” in your cancer (called biomarkers) that cause cancer to grow and spread in different ways. This can help you identify the appropriate treatment plan for you.
Lung nodules are tissue growths that take a round or oval shape. They are fairly common, and most are non-cancerous.
Discover many ways to connect online with other people who have been affected by lung cancer.
Better understand and manage the side effects of conventional cancer therapies such as radiation and chemotherapy.
LUNGevity’s Lung Cancer HELPLine offers toll-free, personalized support for patients and caregivers. Call 833-797-5800 Monday through Friday, 9:00 am to 5:00 pm Eastern time.
A gift of appreciated securities can be a meaningful contribution while also providing the donor a charitable income tax deduction.
Help guide your treatment conversations at every step with this series of questions for healthcare professionals.
Learn about pulmonary rehabilitation, a medically supervised program to help people with lung disease improve their overall physical, mental, and social functioning.
LUNGevity ensures that the lung cancer community is represented in policy by leveraging our research, collaborations, and patients’ voices.
Find out if your employer matches contributions you make to nonprofit organizations. You may be able to double the value of your gift.
View and download checklists to help you prepare for doctor visits and traveling.
Explore additional resources to help you find information on many aspects of living with lung cancer, resources in your area, and specific kinds of assistance.
We fund translational research to move knowledge as quickly as possible from basic discovery to the treatment of patients.
Make friends and find encouragement through our Virtual Meetups for patients, survivors, caregivers, and friends and family members of people with lung cancer.
Understand how the lungs work, how lung cancer develops, and how it can metastasize (spread to another part of the body).
Caregiving may be the most difficult job you ever take on, but one of the most valuable. Discover resources to assist you with this responsibility.
We are committed to supporting research that is patient-centered, drives lung cancer science forward, and generates future research funding.
We use our position as thought leaders to advocate for policy and funding that improves the lives of people living with lung cancer.
Learn how to identify the signs and symptoms of lung cancer and when it may be time to talk to your doctor.
Check out these 10 tips to help you through the caregiver process and download tip sheets on specific aspects of caregiving.
Finding someone who understands what you’re going through isn’t easy. Patients and caregivers can get matched with one-on-one mentors who can help you navigate through the emotions and logistics of life with lung cancer.
Raise money your way and be part of the team that's transforming lung cancer.
Not all lung cancers are the same. Learn about the two major histologic types, small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), which have several subtypes.
As a caregiver, you are in the best position to help your loved one address the practical, logistical, and emotional concerns that go along with an often fast-moving disease. LUNGevity has gathered resources to help you navigate this process.
Are you or a loved one recently diagnosed and wondering what happens now? LUNGevity’s Right Track can guide the way to precision resources and treatment.
The LUNGevity Early Lung Cancer Center is guided by an external advisory board of world-renowned scientists, clinicians, policy makers, and thought leaders.
A highly aggressive type of lung cancer
